Analyst Ranking
Bottom 8%
#4294 out of 4625 analysts
Average Return
Win Rate
40%36 out of 90
Risk vs Reward

Balaji Prasad's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Amneal Pharmaceuticals IncAMRX
2023-03-10 -
Strong Buy
Endo International PLCENDPQ
2022-03-02 -
Strong Sell
Endo International PLCENDPQ
2022-05-09 -
Strong Sell
Revance Therapeutics IncRVNC
2021-10-26 -
Strong Buy
Amneal Pharmaceuticals IncAMRX
2023-08-07 -
Strong Buy

Balaji Prasad Analyst Color

Get additional color on Balaji Prasad's coverage of popular stocks

Balaji Prasad's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Pacira Biosciences IncPCRX
11 days ago
Elanco Animal Health IncELAN
8Strong Buy$21.00+52.06%Maintains
16 days ago
Teva Pharmaceutical Industries LtdTEVA
8Strong Buy$21.00+21.53%Maintains
a month ago
4Strong Buy$22.00+81.07%Maintains
2 months ago
Tarsus Pharmaceuticals IncTARS
3Strong Buy$60.00+103.87%Maintains
2 months ago
Phibro Animal Health CorpPAHC
6Strong Sell$13.00-25.63%Maintains
2 months ago
Dr Reddys Laboratories LtdRDY
10Strong Buy$81.00+1.77%Maintains
2 months ago
Jazz Pharmaceuticals PLCJAZZ
4Strong Buy$200.00+89.41%Maintains
2 months ago
Idexx Laboratories IncIDXX
7Strong Buy$570.00+15.68%Maintains
2 months ago
Zoetis IncZTS
8Strong Buy$230.00+28.46%Maintains
3 months ago
Revance Therapeutics IncRVNC
7Strong Buy$10.00+179.33%Maintains
5 months ago
Amneal Pharmaceuticals IncAMRX
3Strong Buy$8.00+11.27%Maintains
6 months ago
Evolus IncEOLS
4Strong Buy$16.00+35.94%Upgrades
6 months ago
Polypid LtdPYPD
9 months ago
Coherus Biosciences IncCHRS
5Strong Buy$7.00+321.69%Maintains
9 months ago
Organon & CoOGN
1Strong Buy$28.00+31.46%Initiates Coverage On
10 months ago
Ligand Pharmaceuticals IncLGND
9Strong Buy$110.00+10.65%Maintains
a year ago
Viatris IncVTRS
6Strong Sell$11.00N/ADowngrades
a year ago
Rvl Pharmaceuticals PLCRVLPQ
2Strong Buy$2.00N/AMaintains
a year ago
Covetrus IncCVET
2 years ago
Endo International PLCENDPQ
3Strong Sell$1.00N/AMaintains
2 years ago
Amag Pharmaceuticals IncAMAG
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.